Samin Mohsenian/LinkedIn
Jul 17, 2026, 09:42
Samin Mohsenian: Proud to Receive a Top Poster Award at ISTH 2026
Samin Mohsenian, Researcher at Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, shared on LinkedIn:
”It was a pleasure to present our latest findings on congenital Factor X deficiency at ISTH 2026.
In this work, we identified clinically relevant FX activity cut-offs that may support clinical decision-making and improve bleeding risk stratification.
We also explored the genotype–phenotype relationship, highlighting how genetic variants contribute to the clinical heterogeneity observed in patients.
I was also delighted that my poster on congenital Factor VII deficiency received a Top Poster Award.”
Stay updated with Hemostasis Today.
-
Oct 20, 2026, 06:45Grant Garcia: Why Does a Blood Clot Diagnosis Immediately End an Athlete’s Season?
-
Oct 20, 2026, 06:35Parag Tamhankar: Landmark Study Reveals Genetic Spectrum and Targeted Therapies for ALPS in the Indian Population
-
Oct 20, 2026, 06:26Nina Houben: Neonatal Blood Transfusion Symposium and PhD Defense
-
Oct 20, 2026, 05:46Jan T. Kielstein: DNP Poisoning and Hemoadsorption The Limits of Rescue Therapy
-
Oct 20, 2026, 05:33Giulia Di Paolo: Connecting Plasma Donation to the Patients Who Depend on It
-
Oct 20, 2026, 05:20James Knowles: Exploring Plasma Manufacturing and Strengthening Industry Collaboration
-
Oct 20, 2026, 05:11Giuseppe LippiÖ‰ Understanding Liver Test Abnormalities After AAV Gene Therapy
-
Oct 20, 2026, 05:02Sanam Loghavi: Test Your Hematology Knowledge at ASH 2026!
-
Oct 20, 2026, 04:13Ifeanyichukwu Ifechidere: DOACs Are Not the Answer to Every Anticoagulation Question